The key to eradicating tumors and preventing relapses and metastasis is buried within the tumor itself. The tumor cells themselves contain a sort of needle in the haystack. Just 1% of the total volume of the tumor is responsible for reproduction, and a targeted surgery or drugs could be sufficient enough to “deactivate” the tumor and avoid any possibility of a reoccurrence. This type of treatment could possibly change the therapeutic approach to malignant tumors according to an Italian study at the Superior Health Institute (ISS) by Professor Ruggero De Maria, the Director Read More…
Stem cells from umbilical cords are increasingly being stored in private banks for autologous use. “Newsweek” added to the debate writing about Dallas Hextell, who at the age of 8 months was diagnosed with cerebral paralysis, a condition normally caused by serious neural damage due to oxygen deprivation in the uterus or at birth. His parents consulted various neurologists, but the possibility of a recovery was virtually non-existant.
About 9 months later, when given the opportunity to participate in a Duke University clinical study on autologous stem cell transplants (stem cells that are stored for later use by Read More…
The subject of producing artificial blood from stem cells has become a hot topic in Italy. “Italy is close to reaching the same objective announced by British researchers, on a similar timeframe,” therefore possibly in three years, “but using adult stem cells. Certainly, it is one thing to say that in three years we will begin the experimental phase, it’s another thing to speak about industrial production. It needs to be specified that the procedure to produce artificial blood is very expensive. Therefore this would be a complementary solution, which will not replace Read More…
It was stunning to see them closed inside of those plastic bubbles, kept far from all external contact because their immune system does not react against any foreign antigens. Today scientists can say that ADA-SCID (adenosine deaminase deficiency), a serious combined immunodeficiency caused due to a lack of the adenosine deaminase enzyme, has been definitively defeated by gene therapy developed at San Raffaele of Milan.
The final study, which combined the conclusions of clinical studies, which began in 2000 on strategic therapies developed by the HSR-TIGET (San Raffaele Telethon Institute for Gene Therapy) group, led Read More…
Limbus stem cell transplants (a layer of adult stem cells surrounding the cornea responsible for restoring corneal epithelium naturally during life) rebuild the ocular surface when damaged due to chemical and physical agents (like lime). They also repair “injuries” due to improper use of contact lenses. Vincenzo Sarnicola, a cornea and stem cell transplant expert, leading ocular surface specialist in Grosseto, Professor of Ocular Surface Surgery at the University of Siena, and President of the Italian Stem Cell and Ocular Surface Society (SICSSO) explained, “When the ocular surface loses its stem cells it is unable to defend Read More…
